In 2023, the mortality rate for pancreas malignant neoplasms in Japan was 31.8 per hundred thousand women. From 2024 to 2028, the forecast shows a steady increase in mortality rates: from 32.7 in 2024 to 36.4 in 2028. The year-on-year growth rates are approximately 3.06%, 2.67%, 2.6%, and 2.54%, respectively. Over this five-year period, the compound annual growth rate (CAGR) is about 2.75%.
Future trends to watch for include:
- The potential impact of advancements in medical technology and early detection methods on slowing the increase in mortality rate.
- Policy changes in healthcare that could affect access to treatment for pancreatic cancer.
- Shifts in demographic factors, such as aging population, which may influence incidence and mortality rates.
